Enhancing Quality of Life in Chemotherapy Patients: The Role of Oncology Nurses in Advancing SDG 3

Abstract

Chemotherapy remains one of the most commonly used yet physically and emotionally taxing cancer treatments. As patients endure a wide range of side effects—nausea, fatigue, emotional distress, and social withdrawal—the role of oncology nurses in improving quality of life (QoL) becomes increasingly vital. This paper presents a secondary qualitative review of current literature to explore the multifaceted contributions of oncology nurses in enhancing QoL among chemotherapy patients. Drawing upon findings from randomized controlled trials, systematic reviews, and policy papers, the study identifies key areas where oncology nurses exert significant influence: symptom management, emotional support, patient education, therapeutic communication, care coordination, and digital health engagement. Results demonstrate that nurse-led interventions are associated with reduced anxiety, better treatment adherence, improved symptom control, and stronger emotional resilience. Despite their effectiveness, nursing impact is often hindered by workforce shortages, training gaps, and cultural or systemic barriers—particularly in low- and middle-income countries. The study concludes by advocating for greater global investment in oncology nursing infrastructure, training, and policy recognition. Elevating the status and scope of oncology nursing is not merely a professional imperative—it is a critical component of patient-centered cancer care.